BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16801134)

  • 21. [Alteration of genomic structure and/or expression of cancer associated genes in hepatocellular carcinoma].
    Fujimoto Y; Kohgo Y
    Rinsho Byori; 1998 Jan; 46(1):9-14. PubMed ID: 9492532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells.
    Dobra K; Nurminen M; Hjerpe A
    Anticancer Res; 2003; 23(3B):2435-44. PubMed ID: 12894525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.
    Maeda T; Desouky J; Friedl A
    Oncogene; 2006 Mar; 25(9):1408-12. PubMed ID: 16247452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shedding light on the distinct functions of proteoglycans.
    Selleck SB
    Sci STKE; 2006 Apr; 2006(329):pe17. PubMed ID: 16595733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism.
    Chalkiadaki G; Nikitovic D; Berdiaki A; Sifaki M; Krasagakis K; Katonis P; Karamanos NK; Tzanakakis GN
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1323-31. PubMed ID: 19110070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.
    Contreras HR; Fabre M; Granés F; Casaroli-Marano R; Rocamora N; Herreros AG; Reina M; Vilaró S
    Biochem Biophys Res Commun; 2001 Aug; 286(4):742-51. PubMed ID: 11520060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma].
    Péterfia B; Hollósi P; Szilák L; Timár F; Paku S; Jeney A; Kovalszky I
    Magy Onkol; 2006; 50(2):115-20. PubMed ID: 16888674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of tumor cell growth by syndecan-1 ectodomain.
    Mali M; Andtfolk H; Miettinen HM; Jalkanen M
    J Biol Chem; 1994 Nov; 269(45):27795-8. PubMed ID: 7961703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased leukocyte-endothelial interactions in syndecan-1-deficient mice involve heparan sulfate-dependent and -independent steps.
    Götte M; Bernfield M; Joussen AM
    Curr Eye Res; 2005 Jun; 30(6):417-22. PubMed ID: 16020273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells.
    Leppä S; Härkönen P; Jalkanen M
    Cell Regul; 1991 Jan; 2(1):1-11. PubMed ID: 2007184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syndecan-1 in B lymphoid malignancies.
    Sanderson RD; Børset M
    Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells.
    Ohtake T; Fujimoto Y; Ikuta K; Saito H; Ohhira M; Ono M; Kohgo Y
    Br J Cancer; 1999 Oct; 81(3):393-403. PubMed ID: 10507762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling.
    Finsen AV; Woldbaek PR; Li J; Wu J; Lyberg T; Tønnessen T; Christensen G
    Physiol Genomics; 2004 Feb; 16(3):301-8. PubMed ID: 14625378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syndecan-4 dependent FGF stimulation of mouse vibrissae growth.
    Iwabuchi T; Goetinck PF
    Mech Dev; 2006 Nov; 123(11):831-41. PubMed ID: 16989989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syndecan in carcinomas produced from transformed epithelial cells in nude mice.
    Inki P; Kujari H; Jalkanen M
    Lab Invest; 1992 Mar; 66(3):314-23. PubMed ID: 1538586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of syndecan-1 in prostate cancer.
    Kiviniemi J; Kallajoki M; Kujala I; Matikainen MT; Alanen K; Jalkanen M; Salmivirta M
    APMIS; 2004 Feb; 112(2):89-97. PubMed ID: 15056224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Syndecan-4 in the cellular invasion of Orientia tsutsugamushi.
    Kim HR; Choi MS; Kim IS
    Microb Pathog; 2004 Apr; 36(4):219-25. PubMed ID: 15001228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression analysis of Fgf8a &Fgf8b in early stage of P19 cells during neural differentiation.
    Alam AH; Suzuki H; Tsukahara T
    Cell Biol Int; 2009 Sep; 33(9):1032-7. PubMed ID: 19555770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proximal promoter-independent activation of the far-upstream FGF-inducible response element of syndecan-1 gene.
    Jaakkola P; Vihinen T; Jalkanen M
    Biochem Biophys Res Commun; 2000 Nov; 278(2):432-9. PubMed ID: 11097854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2.
    Song SJ; Cool SM; Nurcombe V
    J Cell Biochem; 2007 Feb; 100(2):402-11. PubMed ID: 16924669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.